What is Penumbra, Inc.'s earnings per share (EPS)?

Penumbra, Inc. (PEN) reported diluted earnings per share of $4.52 for fiscal year 2025. This represents a 1155.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Penumbra, Inc. (PEN) Financials

PEN

Trailing 12 months to June 30, 2026

Revenue $1.5B +17.6% YoY

Net Income $160.6M +8.7% YoY

EPS (Diluted) $4.07 +8.0% YoY

Free Cash Flow $215.9M +33.6% YoY

Market Cap $12.6B as of Oct 14, 2026

Price / Sales 8.4x on $1.5B revenue, trailing 12 months to June 30, 2026

Price / Earnings 78.5x on $160.6M net income, trailing 12 months to June 30, 2026

Price / Book 8.2x on $1.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 30, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PEN SEC filings page.

Penumbra, Inc. (PEN) reported $1.5B in revenue over the twelve months to Jun 30, 2026, up 17.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PEN FY2025 2026-10-03

Penumbra's 2025 results show a business converting faster growth into sharply higher margins and cash while keeping leverage modest.

The key shift is earnings quality: operating margin expanded from 0.8% in FY2024 to 13.5% in FY2025. Operating cash flow reached $239M versus net income of $178M, indicating that the improved accounting profit was accompanied by cash generation.

Margin expansion was broader than overhead control alone: gross margin rose from 63.2% in FY2024 to 67.1% in FY2025. Operating margin then widened sharply, showing that more gross profit reached the bottom line as scale or revenue mix changed.

Capital intensity increased as FY2025 capital spending reached $64M, but free cash flow still reached $175M, so reinvestment did not absorb the operating cash produced. A 6.6x current ratio and 0.3x debt-to-equity indicate growth is being financed from a liquid, lightly leveraged balance sheet.

Financial Health Signals

Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Penumbra, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Penumbra, Inc. has an operating margin of 13.5%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 52/100, indicating healthy but not exceptional operating efficiency. This is up from 0.8% the prior year.

Growth

Penumbra, Inc.'s revenue surged 17.5% year-over-year to $1.4B, reflecting rapid business expansion. This strong growth earns a score of 76/100.

Leverage

Penumbra, Inc. carries a low D/E ratio of 0.28, meaning only $0.28 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 70/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 6.64, Penumbra, Inc. holds $6.64 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 95/100.

Cash Flow

Penumbra, Inc. converts 12.5% of revenue into free cash flow ($174.9M). This strong cash generation earns a score of 70/100.

Returns

Penumbra, Inc.'s ROE of 12.4% shows moderate profitability relative to equity, earning a score of 47/100. This is up from 1.2% the prior year.

Altman Z-Score Safe

20.93

Penumbra, Inc. scores 20.93, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($12.6B) relative to total liabilities ($398.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Penumbra, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.34x

For every $1 of reported earnings, Penumbra, Inc. generates $1.34 in operating cash flow ($238.7M OCF vs $177.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

144.35x

Penumbra, Inc. earns $144.35 in operating income for every $1 of interest expense ($189.2M vs $1.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$390.0M

YoY+14.9%

QoQ+4.1%

5Y CAGR+16.2%

10Y CAGR+19.6%

Penumbra, Inc. generated $390.0M in revenue in Q2 2026. This represents an increase of 14.9% from the same quarter a year earlier. Against the prior quarter it is up 4.1%.

EBITDA

$46.7M

YoY+0.7%

QoQ+9.0%

Penumbra, Inc.'s EBITDA was $46.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.7% from the same quarter a year earlier. Against the prior quarter it is up 9.0%.

Net Income

$34.8M

YoY-23.1%

QoQ+6.8%

5Y CAGR+30.4%

10Y CAGR+27.7%

Penumbra, Inc. reported $34.8M in net income in Q2 2026. This represents a decrease of 23.1% from the same quarter a year earlier. Against the prior quarter it is up 6.8%.

EPS (Diluted)

$0.88

YoY-23.5%

QoQ+7.3%

5Y CAGR+28.6%

10Y CAGR+25.6%

Penumbra, Inc. earned $0.88 per diluted share (EPS) in Q2 2026. This represents a decrease of 23.5% from the same quarter a year earlier. Against the prior quarter it is up 7.3%.

Cash & Balance Sheet

Free Cash Flow

$32.5M

YoY+10.8%

QoQ-55.6%

Penumbra, Inc. generated $32.5M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 10.8% from the same quarter a year earlier. Against the prior quarter it is down 55.6%.

Cash & Debt

$205.3M

YoY-51.3%

QoQ-14.9%

5Y CAGR+20.1%

10Y CAGR+30.9%

Penumbra, Inc. held $205.3M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

39M

YoY+1.0%

QoQ+0.1%

5Y CAGR+1.5%

10Y CAGR+2.4%

Penumbra, Inc. had 39M shares outstanding in Q2 2026. This represents an increase of 1.0% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

67.9%

YoY+1.9pp

QoQ+0.3pp

5Y change+3.5pp

10Y change+4.2pp

Penumbra, Inc.'s gross margin was 67.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin

10.5%

YoY-1.5pp

QoQ+0.3pp

Penumbra, Inc.'s operating margin was 10.5% in Q2 2026, reflecting core business profitability. This is down 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Net Margin

8.9%

YoY-4.4pp

QoQ+0.2pp

5Y change+3.9pp

10Y change+4.3pp

Penumbra, Inc.'s net profit margin was 8.9% in Q2 2026, showing the share of revenue converted to profit. This is down 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Return on Equity

2.3%

YoY-1.2pp

QoQ+0.1pp

5Y change+0.9pp

10Y change+1.1pp

Penumbra, Inc.'s ROE was 2.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Capital Allocation

R&D Spending

$25.4M

YoY+9.4%

QoQ+13.5%

Penumbra, Inc. invested $25.4M in research and development in Q2 2026. This represents an increase of 9.4% from the same quarter a year earlier. Against the prior quarter it is up 13.5%.

Capital Expenditures

$13.5M

YoY-13.1%

QoQ-0.9%

5Y CAGR+32.7%

10Y CAGR+18.0%

Penumbra, Inc. invested $13.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 13.1% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Share Buybacks

Not reported for Q2 2026.

PEN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PEN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Revenue	$1.5B	$1.4B+17.5%	$1.2B+12.9%	$1.1B+25.0%	$847.1M+13.3%	$747.6M+33.4%	$560.4M+2.4%	$547.4M+23.0%	$444.9M+33.3%	$333.8M+26.8%	$263.3M+41.5%	$186.1M+48.3%	$125.5M+41.3%	$88.8M
Cost of Revenue	$484.0M	$461.2M+4.9%	$439.6M+17.0%	$375.9M+20.5%	$311.9M+14.6%	$272.2M+22.5%	$222.2M+26.7%	$175.4M+15.1%	$152.4M+30.7%	$116.6M+26.1%	$92.5M+49.1%	$62.0M+45.4%	$42.7M+37.8%	$31.0M
Gross Profit	$1.0B	$942.4M+24.8%	$755.0M+10.6%	$682.6M+27.5%	$535.2M+12.6%	$475.4M+40.6%	$338.2M-9.1%	$372.0M+27.2%	$292.5M+34.7%	$217.1M+27.1%	$170.8M+37.7%	$124.1M+49.8%	$82.8M+43.1%	$57.9M
R&D Expenses	$92.2M	$89.8M-5.3%	$94.8M+12.3%	$84.4M+6.3%	$79.4M-24.1%	$104.6M+16.1%	$90.0M+74.1%	$51.7M+43.0%	$36.2M+14.2%	$31.7M+32.6%	$23.9M+32.4%	$18.0M+15.7%	$15.6M+10.6%	$14.1M
SG&A Expenses	$741.3M	$663.4M+15.6%	$574.0M+13.3%	$506.5M+12.6%	$449.7M+18.9%	$378.3M+31.8%	$287.1M+5.3%	$272.7M+20.5%	$226.4M+22.8%	$184.3M+24.3%	$148.3M+45.6%	$101.9M+58.5%	$64.3M+43.1%	$44.9M
Operating Income	$187.3M	$189.2M+1939.5%	$9.3M-87.4%	$73.6M+1109.3%	$6.1M+181.1%	-$7.5M+80.7%	-$38.9M-182.0%	$47.5M+5676.1%	-$852K-173.1%	$1.2M+186.3%	-$1.4M-132.3%	$4.2M+38.9%	$3.0M+367.2%	-$1.1M
EBITDA	N/A	$206.7M+526.8%	$33.0M-67.3%	$100.8M+231.6%	$30.4M+241.3%	$8.9M+134.2%	-$26.1M-146.8%	$55.6M+946.1%	$5.3M+7.5%	$4.9M+422.3%	$947K-84.0%	$5.9M+57.7%	$3.8M+937.4%	-$449K
Interest Expense	$1.3M	$1.3M-7.5%	$1.4M-18.5%	$1.7M-0.6%	$1.7M-9.5%	$1.9M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$43.2M	$27.4M+300.1%	$6.9M+160.7%	-$11.3M-291.8%	$5.9M+144.9%	-$13.1M+30.0%	-$18.8M-699.2%	$3.1M+171.1%	-$4.4M-21.9%	-$3.6M+77.0%	-$15.7M-1045.3%	$1.7M+85.6%	$894K+116.7%	-$5.4M
Net Income	$160.6M	$177.7M+1168.1%	$14.0M-84.6%	$91.0M+4643.2%	-$2.0M-137.9%	$5.3M+133.7%	-$15.7M-132.4%	$48.5M+634.1%	$6.6M+41.7%	$4.7M-68.6%	$14.8M+526.4%	$2.4M+5.3%	$2.2M-45.2%	$4.1M
EPS (Basic)	N/A	$4.57+1169.4%	$0.36-84.8%	$2.37+4840.0%	-$0.05-135.7%	$0.14+131.8%	-$0.44-131.7%	$1.39+631.6%	$0.19+35.7%	$0.14-71.4%	$0.49+444.4%	$0.09+150.0%	-$0.18-185.7%	$0.21
EPS (Diluted)	$4.07	$4.52+1155.6%	$0.36-84.5%	$2.32+4740.0%	-$0.05-135.7%	$0.14+131.8%	-$0.44-132.8%	$1.34+644.4%	$0.18+38.5%	$0.13-70.5%	$0.44+450.0%	$0.08	-$0.18-228.6%	$0.14
Diluted Shares (Avg)	N/A	39M+0.1%	39M+0.1%	39M+3.6%	38M-0.1%	38M+5.9%	36M-1.4%	36M+0.5%	36M+2.2%	35M+5.5%	33M+135.4%	14M	5M-29.1%	7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$390.0M+14.9%	$374.8M+15.6%	$385.4M+22.1%	$354.7M+17.8%	$339.5M+13.4%	$324.1M+16.3%	$315.5M+10.8%	$301.0M+11.1%
Cost of Revenue	$125.1M+8.4%	$121.3M+12.1%	$123.3M+17.6%	$114.3M+13.4%	$115.4M-15.5%	$108.3M+11.0%	$104.8M+7.3%	$100.7M+8.1%
Gross Profit	$264.9M+18.3%	$253.4M+17.4%	$262.1M+24.4%	$240.4M+20.0%	$224.0M+37.6%	$215.9M+19.2%	$210.7M+12.7%	$200.3M+12.7%
R&D Expenses	$25.4M+9.4%	$22.4M+1.4%	$21.8M+8.9%	$22.7M-10.0%	$23.2M-6.9%	$22.1M-10.4%	$20.0M	$25.2M+20.3%
SG&A Expenses	$198.5M+24.1%	$192.8M+25.6%	$181.1M+22.4%	$168.9M+20.9%	$160.0M+12.7%	$153.5M+6.3%	$147.9M	$139.7M+11.0%
Operating Income	$41.0M+0.5%	$38.2M-5.2%	$59.2M+38.5%	$48.8M+38.1%	$40.8M+150.4%	$40.4M+233.4%	$42.8M	$35.4M+180.1%
EBITDA	$46.7M+0.7%	$42.8M-5.6%	$63.7M+35.1%	$51.3M+29.9%	$46.3M+163.2%	$45.4M+131.2%	$47.2M	$39.5M+102.0%
Interest Expense	$311K-2.5%	$317K-1.6%	$332K-1.2%	$338K+0.6%	$319K-7.3%	$322K-19.9%	$336K	$336K-24.0%
Income Tax	$11.4M+28340.0%	$9.1M+96.4%	$16.3M+52.9%	$6.5M-36.8%	$40K+100.2%	$4.6M+27.9%	$10.7M+166.4%	$10.3M+150.6%
Net Income	$34.8M-23.1%	$32.6M-16.9%	$47.3M+40.6%	$45.9M+55.3%	$45.3M+175.2%	$39.2M+256.5%	$33.7M-37.9%	$29.5M+220.5%
EPS (Basic)	$0.88-24.8%	$0.83-18.6%	$1.21+39.1%	$1.17+53.9%	$1.17+175.5%	$1.02+264.3%	$0.87-37.9%	$0.76+216.7%
EPS (Diluted)	$0.88-23.5%	$0.82-18.0%	$1.20+37.9%	$1.17+56.0%	$1.15+174.2%	$1.00+257.1%	$0.87-37.0%	$0.75+226.1%
Diluted Shares (Avg)	40M+0.8%	40M+1.0%	N/A	39M+0.3%	39M+1.2%	39M-0.6%	N/A	39M-0.1%

PEN Balance Sheet

PEN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Total Assets	$1.8B+19.1%	$1.5B-1.5%	$1.6B+13.5%	$1.4B+10.2%	$1.2B+51.2%	$823.0M+23.6%	$665.9M+29.3%	$515.0M+8.0%	$476.7M+54.6%	$308.3M+16.8%	$263.8M+117.4%	$121.4M	N/A
Current Assets	$1.2B+27.9%	$951.1M+3.9%	$915.4M+21.1%	$755.7M+10.9%	$681.5M+10.3%	$617.7M+33.4%	$463.1M+12.8%	$410.7M+7.5%	$382.2M+44.9%	$263.8M+8.0%	$244.4M+111.9%	$115.3M	N/A
Cash & Equivalents	$186.9M-42.4%	$324.4M+93.7%	$167.5M+139.8%	$69.9M+17.6%	$59.4M-14.8%	$69.7M-4.3%	$72.8M+7.3%	$67.8M+34.0%	$50.6M+282.6%	$13.2M-32.3%	$19.5M+494.1%	$3.3M-20.4%	$4.1M
Short-Term Investments	$357.9M+2175.8%	$15.7M-87.1%	$121.7M+3.0%	$118.2M-39.6%	$195.5M+0.2%	$195.2M+67.4%	$116.6M-12.3%	$133.0M-18.9%	$164.0M+41.9%	$115.5M-10.6%	$129.3M+167.9%	$48.3M	$0
Inventory	$431.5M+6.1%	$406.7M+4.8%	$388.0M+16.2%	$334.0M+26.8%	$263.5M+20.0%	$219.5M+43.5%	$153.0M+32.2%	$115.7M+22.0%	$94.9M+30.0%	$73.0M+28.6%	$56.8M+69.7%	$33.5M	N/A
Accounts Receivable	$190.0M+13.3%	$167.7M-16.9%	$201.8M-0.8%	$203.4M+51.8%	$133.9M+16.9%	$114.6M+8.2%	$105.9M+29.3%	$81.9M+41.2%	$58.0M+33.9%	$43.3M+47.2%	$29.4M+55.7%	$18.9M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$3.9M	$0	$0	$0	$0
Goodwill	$166.8M+0.6%	$165.8M-0.3%	$166.3M+0.1%	$166.0M-0.2%	$166.4M+1887.4%	$8.4M+9.4%	$7.7M-2.0%	$7.8M-4.5%	$8.2M	$0	N/A	N/A	N/A
Total Liabilities	$398.9M+4.4%	$382.3M+1.3%	$377.4M+1.4%	$372.0M+28.1%	$290.3M+56.8%	$185.2M+2.7%	$180.3M+94.7%	$92.6M+21.4%	$76.3M+82.8%	$41.7M+33.1%	$31.3M-76.6%	$133.8M	N/A
Current Liabilities	$183.1M+15.7%	$158.3M+4.8%	$151.1M+4.3%	$144.9M+17.6%	$123.2M+16.3%	$105.9M+16.3%	$91.0M+37.8%	$66.1M+28.1%	$51.6M+44.1%	$35.8M+27.2%	$28.1M+35.2%	$20.8M	N/A
Non-Current Liabilities	$215.8M-3.6%	$223.9M-1.0%	$226.2M-0.4%	$227.1M+35.9%	$167.1M+110.8%	$79.3M-11.2%	$89.2M+236.4%	$26.5M+7.5%	$24.7M+317.8%	$5.9M+85.9%	$3.2M-97.2%	$112.9M	N/A
Total Equity	$1.4B+24.0%	$1.2B-2.4%	$1.2B+18.0%	$998.9M+4.7%	$953.9M+48.7%	$641.5M+32.0%	$485.9M+15.1%	$422.2M+5.5%	$400.4M+50.2%	$266.5M+14.6%	$232.5M+1979.7%	-$12.4M-53.4%	-$8.1M
Retained Earnings	$237.7M+296.1%	$60.0M-55.5%	$134.9M+207.2%	$43.9M-4.4%	$45.9M+13.0%	$40.6M-29.4%	$57.5M+534.6%	$9.1M+354.1%	$2.0M+175.0%	-$2.7M+84.8%	-$17.5M+11.9%	-$19.8M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$2.0B+17.9%	$1.9B+19.2%	$1.8B+19.1%	$1.7B+17.9%	$1.7B+9.1%	$1.6B+0.9%	$1.5B-1.5%	$1.5B+0.7%
Current Assets	$1.3B+26.2%	$1.3B+27.6%	$1.2B+27.9%	$1.1B+28.0%	$1.1B+12.9%	$999.7M+6.9%	$951.1M+3.9%	$891.8M+2.7%
Cash & Equivalents	$205.3M-51.3%	$241.3M-35.8%	$186.9M-42.4%	$321.0M+14.5%	$421.8M+46.3%	$376.1M+68.5%	$324.4M+93.7%	$280.5M+178.4%
Short-Term Investments	$453.5M+16126.3%	$374.4M+13299.1%	$357.9M+2175.8%	$149.3M+1315.1%	$2.8M-94.6%	$2.8M-96.9%	$15.7M-87.1%	$10.5M-92.9%
Inventory	$442.6M+3.5%	$438.5M+5.5%	$431.5M+6.1%	$432.4M+9.9%	$427.6M+14.4%	$415.9M+4.4%	$406.7M+4.8%	$393.4M+5.1%
Accounts Receivable	$190.4M+8.5%	$183.3M+9.1%	$190.0M+13.3%	$183.4M+4.2%	$175.5M-12.6%	$168.0M-12.5%	$167.7M-16.9%	$176.1M-14.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$166.5M-0.1%	$166.6M+0.3%	$166.8M+0.6%	$166.7M+0.2%	$166.8M+0.4%	$166.1M0.0%	$165.8M-0.3%	$166.4M+0.2%
Total Liabilities	$444.0M+16.6%	$424.6M+11.6%	$398.9M+4.4%	$385.7M+2.9%	$380.9M+2.0%	$380.4M+1.1%	$382.3M+1.3%	$374.8M+2.9%
Current Liabilities	$233.8M+48.2%	$211.7M+33.5%	$183.1M+15.7%	$169.6M+10.7%	$157.8M+4.5%	$158.6M+3.8%	$158.3M+4.8%	$153.2M+5.6%
Non-Current Liabilities	$210.2M-5.8%	$212.9M-4.0%	$215.8M-3.6%	$216.1M-2.5%	$223.1M+0.3%	$221.8M-0.8%	$223.9M-1.0%	$221.7M+1.1%
Total Equity	$1.5B+18.3%	$1.5B+21.5%	$1.4B+24.0%	$1.4B+23.0%	$1.3B+11.4%	$1.2B+0.8%	$1.2B-2.4%	$1.1B0.0%
Retained Earnings	$305.1M+111.1%	$270.3M+172.4%	$237.7M+296.1%	$190.3M+631.8%	$144.5M+68.7%	$99.2M-32.0%	$60.0M-55.5%	$26.0M-67.7%

Not reported in any period shown, so not listed: Long-Term Debt.

PEN Cash Flow Statement

PEN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Operating Cash Flow	$277.8M	$238.7M+41.7%	$168.5M+73.1%	$97.3M+274.9%	-$55.7M-685.8%	$9.5M+128.6%	-$33.2M-224.7%	$26.7M-7.5%	$28.8M+127.0%	$12.7M+199.1%	-$12.8M+38.1%	-$20.7M-223.8%	-$6.4M-88.1%	-$3.4M
Depreciation & Amortization	N/A	$17.5M-26.3%	$23.7M-13.0%	$27.3M+12.1%	$24.3M+48.2%	$16.4M+27.3%	$12.9M+59.1%	$8.1M+31.4%	$6.2M+63.1%	$3.8M+64.6%	$2.3M+31.1%	$1.8M+133.3%	$751K+10.9%	$677K
Stock-Based Compensation	N/A	$59.2M+28.3%	$46.2M-8.6%	$50.5M+35.1%	$37.4M-43.2%	$65.8M+157.5%	$25.5M+18.9%	$21.5M+16.6%	$18.4M+3.4%	$17.8M+21.7%	$14.6M+101.3%	$7.3M+407.4%	$1.4M+61.7%	$886K
Capital Expenditures	$61.9M	$63.7M+200.9%	$21.2M+39.2%	$15.2M-21.2%	$19.3M-8.9%	$21.2M-14.4%	$24.8M+12.0%	$22.1M+130.2%	$9.6M-23.4%	$12.5M-8.1%	$13.6M+149.1%	$5.5M+40.8%	$3.9M+387.2%	$798K
Free Cash Flow	$215.9M	$174.9M+18.8%	$147.3M+79.4%	$82.1M+209.6%	-$75.0M-541.9%	-$11.7M+79.9%	-$58.0M-1376.6%	$4.5M-76.3%	$19.2M+11978.6%	$159K+100.6%	-$26.4M-1.1%	-$26.2M-154.6%	-$10.3M-145.0%	-$4.2M
Investing Cash Flow	-$510.2M	-$404.6M-621.2%	$77.6M+582.9%	-$16.1M-129.3%	$54.8M+352.1%	-$21.7M+79.1%	-$104.1M-719.4%	-$12.7M-3201.6%	-$385K+99.5%	-$77.7M-11403.2%	$687K+100.8%	-$85.8M-131.9%	-$37.0M-2857.7%	-$1.3M
Financing Cash Flow	$16.1M	$26.5M+130.5%	-$87.0M-637.0%	$16.2M+39.4%	$11.6M+1290.2%	$836K-99.4%	$134.9M+1605.9%	-$9.0M+8.7%	-$9.8M-109.4%	$104.4M+1364.5%	$7.1M-94.2%	$122.8M+186.3%	$42.9M+1869.6%	$2.2M
Share Buybacks	N/A	$0-100.0%	$100.4M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$46.1M+2.5%	$87.0M+77.6%	$86.5M+69.2%	$58.3M+3.2%	$44.9M+98.8%	$49.0M+27.9%	$51.1M+40.9%	$56.5M+83.1%
Depreciation & Amortization	$5.6M+2.0%	$4.6M-8.8%	$4.5M+1.7%	$2.5M-40.0%	$5.5M-28.0%	$5.0M-33.3%	$4.4M-37.7%	$4.1M-40.2%
Stock-Based Compensation	$13.7M-4.0%	$14.6M+6.2%	N/A	$15.9M+45.6%	$14.2M+48.9%	$13.8M+1.6%	N/A	$10.9M-22.6%
Capital Expenditures	$13.5M-13.1%	$13.7M+1.5%	$18.4M+243.2%	$16.2M+198.1%	$15.6M+243.5%	$13.5M+131.2%	$5.4M+47.4%	$5.5M+63.6%
Free Cash Flow	$32.5M+10.8%	$73.3M+106.5%	$68.0M+48.8%	$42.0M-17.6%	$29.4M+62.5%	$35.5M+9.3%	$45.7M+40.2%	$51.0M+85.4%
Investing Cash Flow	-$91.1M-484.7%	-$30.6M-6002.2%	-$225.6M-1959.8%	-$162.9M-555.9%	-$15.6M-145.2%	-$502K-102.7%	-$11.0M-145.1%	$35.7M+180.5%
Financing Cash Flow	$9.0M-39.1%	-$1.9M-170.4%	$5.1M-16.7%	$4.0M+103.9%	$14.8M+79.1%	$2.7M+441.1%	$6.1M+2.5%	-$100.6M-47531.1%
Share Buybacks	N/A	N/A	$0-100.0%	N/A	N/A	N/A	-$1K	N/A

Not reported in any period shown, so not listed: Dividends Paid.

PEN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PEN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Gross Margin	67.1%+3.9pp	63.2%-1.3pp	64.5%+1.3pp	63.2%-0.4pp	63.6%+3.2pp	60.3%-7.6pp	68.0%+2.2pp	65.8%+0.7pp	65.1%+0.2pp	64.9%-1.8pp	66.7%+0.7pp	66.0%+0.9pp	65.1%
Operating Margin	13.5%+12.7pp	0.8%-6.2pp	7.0%+6.2pp	0.7%+1.7pp	-1.0%+6.0pp	-7.0%-15.6pp	8.7%+8.9pp	-0.2%-0.5pp	0.4%+0.9pp	-0.5%-2.8pp	2.3%-0.2pp	2.4%+3.7pp	-1.3%
Net Margin	12.7%+11.5pp	1.2%-7.4pp	8.6%+8.8pp	-0.2%-0.9pp	0.7%+3.5pp	-2.8%-11.6pp	8.8%+7.4pp	1.5%+0.1pp	1.4%-4.2pp	5.6%+4.4pp	1.3%-0.5pp	1.8%-2.8pp	4.6%
Return on Equity	12.4%+11.2pp	1.2%-6.5pp	7.7%+7.9pp	-0.2%-0.8pp	0.5%+3.0pp	-2.5%-12.4pp	10.0%+8.4pp	1.6%+0.4pp	1.2%-4.4pp	5.6%+4.5pp	1.0%	N/A	N/A
Return on Assets	9.7%+8.8pp	0.9%-4.9pp	5.8%+6.0pp	-0.1%-0.6pp	0.4%+2.3pp	-1.9%-9.2pp	7.3%+6.0pp	1.3%+0.3pp	1.0%-3.8pp	4.8%+3.9pp	0.9%-0.9pp	1.8%	N/A
Current Ratio	6.64+0.6x	6.010.0x	6.06+0.8x	5.21-0.3x	5.53-0.3x	5.83+0.7x	5.09-1.1x	6.22-1.2x	7.410.0x	7.37-1.3x	8.68+3.1x	5.54	N/A
Debt-to-Equity	0.28-0.1x	0.330.0x	0.32-0.1x	0.37+0.1x	0.300.0x	0.29-0.1x	0.37+0.2x	0.220.0x	0.190.0x	0.160.0x	0.13	N/A	N/A
Asset Turnover	0.770.0x	0.78+0.1x	0.68+0.1x	0.620.0x	0.60-0.1x	0.68-0.1x	0.820.0x	0.86+0.2x	0.70-0.2x	0.85+0.1x	0.71-0.3x	1.03	N/A
FCF Margin	12.5%+0.1pp	12.3%+4.6pp	7.8%+16.6pp	-8.8%-7.3pp	-1.6%+8.8pp	-10.3%-11.2pp	0.8%-3.5pp	4.3%+4.3pp	0.1%+10.1pp	-10.0%+4.0pp	-14.1%-5.9pp	-8.2%-3.5pp	-4.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	67.9%+1.9pp	67.6%+1.0pp	68.0%+1.2pp	67.8%+1.2pp	66.0%+11.6pp	66.6%+1.6pp	66.8%+1.1pp	66.5%+0.9pp
Operating Margin	10.5%-1.5pp	10.2%-2.3pp	15.4%+1.8pp	13.8%+2.0pp	12.0%+39.1pp	12.4%+8.1pp	13.6%	11.8%+7.1pp
Net Margin	8.9%-4.4pp	8.7%-3.4pp	12.3%+1.6pp	12.9%+3.1pp	13.3%+33.5pp	12.1%+8.1pp	10.7%-8.4pp	9.8%+6.4pp
Return on Equity	2.3%-1.2pp	2.2%-1.0pp	3.3%+0.4pp	3.4%+0.7pp	3.5%+8.7pp	3.2%+2.3pp	2.9%-1.7pp	2.7%+1.8pp
Return on Assets	1.8%-0.9pp	1.7%-0.7pp	2.6%+0.4pp	2.6%+0.6pp	2.7%+6.6pp	2.5%+1.8pp	2.2%-1.3pp	2.0%+1.4pp
Current Ratio	5.75-1.0x	6.02-0.3x	6.64+0.6x	6.73+0.9x	6.75+0.5x	6.30+0.2x	6.010.0x	5.82-0.2x
Debt-to-Equity	0.290.0x	0.290.0x	0.28-0.1x	0.28-0.1x	0.290.0x	0.310.0x	0.330.0x	0.340.0x
Asset Turnover	0.200.0x	0.200.0x	0.210.0x	0.200.0x	0.200.0x	0.200.0x	0.210.0x	0.200.0x
FCF Margin	8.3%-0.3pp	19.6%+8.6pp	17.7%+3.2pp	11.8%-5.1pp	8.6%+2.6pp	10.9%-0.7pp	14.5%+3.0pp	17.0%+6.8pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Penumbra, Inc. PEN	FY2025	$1.4B	$177.7M	12.7%	$12.6B	68/100
Smith & Nephew plc SNN	FY2025	$6.2B	$625.0M	10.1%	$11.6B	35/100
Zimmer Biomet Holdings, Inc. ZBH	FY2025	$8.2B	$705.1M	8.6%	$17.6B	59/100
STERIS plc STE	FY2026	$5.9B	$782.3M	13.2%	$21.4B	66/100
Insulet Corporation PODD	FY2025	$2.7B	$247.1M	9.1%	$9.7B	75/100

Where Penumbra, Inc. Ranks

Frequently Asked Questions

What is Penumbra, Inc.'s annual revenue?

Penumbra, Inc. (PEN) reported $1.4B in total revenue for fiscal year 2025. This represents a 17.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Penumbra, Inc.'s revenue growing?

Penumbra, Inc. (PEN) revenue grew by 17.5% year-over-year, from $1.2B to $1.4B in fiscal year 2025.

Is Penumbra, Inc. profitable?

Yes, Penumbra, Inc. (PEN) reported a net income of $177.7M in fiscal year 2025, with a net profit margin of 12.7%.

What is Penumbra, Inc.'s EBITDA?

Penumbra, Inc. (PEN) had EBITDA of $206.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Penumbra, Inc.'s gross margin?

Penumbra, Inc. (PEN) had a gross margin of 67.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Penumbra, Inc.'s operating margin?

Penumbra, Inc. (PEN) had an operating margin of 13.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Penumbra, Inc.'s net profit margin?

Penumbra, Inc. (PEN) had a net profit margin of 12.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Penumbra, Inc.'s return on equity (ROE)?

Penumbra, Inc. (PEN) has a return on equity of 12.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Penumbra, Inc.'s free cash flow?

Penumbra, Inc. (PEN) generated $174.9M in free cash flow during fiscal year 2025. This represents a 18.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Penumbra, Inc.'s operating cash flow?

Penumbra, Inc. (PEN) generated $238.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Penumbra, Inc.'s total assets?

Penumbra, Inc. (PEN) had $1.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Penumbra, Inc.'s capital expenditures?

Penumbra, Inc. (PEN) invested $63.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Penumbra, Inc. spend on research and development?

Penumbra, Inc. (PEN) invested $89.8M in research and development during fiscal year 2025.

How many shares does Penumbra, Inc. have outstanding?

Penumbra, Inc. (PEN) had 39M shares outstanding as of fiscal year 2025.

What is Penumbra, Inc.'s current ratio?

Penumbra, Inc. (PEN) had a current ratio of 6.64 as of fiscal year 2025, which is generally considered healthy.

What is Penumbra, Inc.'s debt-to-equity ratio?

Penumbra, Inc. (PEN) had a debt-to-equity ratio of 0.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Penumbra, Inc.'s return on assets (ROA)?

Penumbra, Inc. (PEN) had a return on assets of 9.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Penumbra, Inc.'s P/E ratio?

Penumbra, Inc. (PEN) trades at 78.5x earnings, its market capitalization divided by net income of $160.6M net income, trailing 12 months to June 30, 2026. The market capitalization is $12.6B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Penumbra, Inc.'s price-to-sales ratio?

Penumbra, Inc. (PEN) trades at 8.4x sales, its market capitalization divided by revenue of $1.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $12.6B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Penumbra, Inc.'s Altman Z-Score?

Penumbra, Inc. (PEN) has an Altman Z-Score of 20.93, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Penumbra, Inc.'s Piotroski F-Score?

Penumbra, Inc. (PEN) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Penumbra, Inc.'s earnings high quality?

Penumbra, Inc. (PEN) has an earnings quality ratio of 1.34x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Penumbra, Inc. cover its interest payments?

Penumbra, Inc. (PEN) has an interest coverage ratio of 144.35x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Penumbra, Inc.?

Penumbra, Inc. (PEN) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.